
Pharmaceutical giant Johnson & Johnson (J&J) announced a landmark settlement agreement of $5.5 billion to resolve the remaining vast majority of lawsuits alleging that its talc-based products (such as baby powder) caused ovarian cancer.

Pharmaceutical giant Johnson & Johnson (J&J) announced a landmark settlement agreement of $5.5 billion to resolve the remaining vast majority of lawsuits alleging that its talc-based products (such as baby powder) caused ovarian cancer.
India Business & Trade is a national media platform decoding the ideas, decisions and shifts shaping India’s growth story—across plicy, business, global commerce and a rapidly evolving marketplace.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved